Investing Ideas
/
Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Swiss Pharmaceuticals & Biotech Potentially Undervalued Companies

Name: Financial Insights Based on S&P Global Market Intelligence
Creator: Simply Wall St Pty Ltd
License: https://www.spglobal.com/content/dam/spglobal/corporate/en/documents/secure/MI-FastTrack-Terms-and-Conditions-July-2023.pdf

Results

0 new

Companies with a Value score of at least 3, ordered by Value score

35 companies

Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
GXI Gerresheimer	CHF 75.60	0%	0%	CHF 2.5b	CHF 120.23	PE21.5x	E21.8%	1.8%
TEVA Teva Pharmaceutical Industries	CHF 7.85	0%	0%	CHF 18.6b	CHF 10.69	PS1.1x	E65.8%	0%
NOVN Novartis	CHF 88.70	1.2%	4.5%	CHF 177.3b	CHF 103.92	PE16.6x	E7.0%	3.7%
SDZ Sandoz Group	CHF 37.17	0.3%	37.4%	CHF 16.3b	CHF 43.50	PS1.8x	E34.9%	1.2%
001102657 GSK	CHF 26.12	0%	-2.8%	CHF 70.6b	CHF 34.09	PE13.8x	E8.9%	5.7%
RO Roche Holding	CHF 270.60	2.3%	3.5%	CHF 205.2b	CHF 321.29	PE19.2x	E11.5%	3.8%
ROG Roche Holding	CHF 255.50	1.8%	4.5%	CHF 205.2b	CHF 303.36	PE19.2x	E11.5%	3.8%
BMY Bristol-Myers Squibb	CHF 54.24	0%	0%	CHF 100.3b	CHF 58.46	PS2.2x	E49.0%	4.8%
BAYN Bayer	CHF 67.99	0%	-66.0%	CHF 18.9b	CHF 98.75	PS0.4x	E55.8%	0.6%
COPN Cosmo Pharmaceuticals	CHF 63.70	4.1%	25.1%	CHF 1.0b	CHF 97.30	PE15.6x	E17.2%	3.0%
JCARE Joincare Pharmaceutical Group IndustryLtd	US$8.00	0%	0%	US$21.6b	US$9.62	PE14.7x	E11.8%	1.6%
SANN Santhera Pharmaceuticals Holding	CHF 13.82	20.8%	40.9%	CHF 167.3m	CHF 32.00	PE2.7x	E35.4%	n/a
NOVNEE Novartis	CHF 88.47	0.9%	4.6%	CHF 177.3b	CHF 103.65	PE16.6x	E7.0%	3.7%
MER Merck KGaA	CHF 130.26	1.7%	n/a	CHF 60.8b	CHF 171.02	PE22.6x	E11.1%	1.6%
J7Z Jazz Pharmaceuticals	CHF 112.57	n/a	n/a	CHF 7.5b	CHF 163.57	PE16.3x	E16.3%	n/a
QIA Qiagen	CHF 50.36	0%	0%	CHF 9.2b	CHF 61.37	PE27x	E11.3%	n/a
000935700 Gilead Sciences	CHF 68.48	0%	10.5%	CHF 94.1b	CHF 82.84	PE17.2x	E7.8%	4.0%
EVT Evotec	CHF 27.76	0%	0%	CHF 1.9b	CHF 29.26	PS2.4x	E74.2%	n/a
000943981 Johnson & Johnson	CHF 131.02	1.2%	-0.3%	CHF 349.2b	CHF 157.43	PE23.6x	E10.6%	3.4%
BIIB Biogen	CHF 222.00	0%	0%	CHF 27.0b	CHF 320.85	PE23.3x	E17.1%	n/a
000982352 AstraZeneca	CHF 119.95	1.4%	6.1%	CHF 161.4b	CHF 160.65	PE31.1x	E18.2%	2.2%
OBSN ObsEva	CHF 0.0012	0%	-98.2%	CHF 140.6k	n/a	PE0.02x	n/a	n/a
010683053 Merck	CHF 90.15	0.9%	n/a	CHF 252.2b	CHF 116.40	PE20.8x	E16.0%	3.2%
XLS Xlife Sciences	CHF 25.40	-1.6%	-49.1%	CHF 145.8m	n/a	PE6.9x	n/a	n/a

Page 1 of 2